• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Are Neuromodulating Medications Effective for Treatment of Chronic Neurogenic Cough?

by John Paul Giliberto, MD, Seth M. Cohen, MD, and Stephanie Misono, MD • November 9, 2017

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

TRIO Best Practice

You Might Also Like

  • Superior Laryngeal Nerve Block May Be a Viable Treatment Option for Neurogenic Cough
  • Procedural Therapies Demonstrate Effectiveness in Improving the Lives of Patients with Neurogenic Cough
  • Neurogenic Cough Is Often a Diagnosis of Exclusion
  • Superior Laryngeal Nerve Block Improves Neurogenic Cough for Most
Explore This Issue
November 2017

Background

Chronic cough is vexing for patients and is an extremely common chief complaint in ambulatory settings. A cough persisting longer than eight weeks is considered chronic, and many patients seek evaluation by an otolaryngologist. After considering a broad differential, including reflux, chronic rhinitis/sinusitis, primary pulmonary diagnosis, and medication side effects, the diagnosis of chronic neurogenic cough can be considered.

Both peripheral neuropathy and central sensitization/potentiation of the cough reflex have been implicated in the pathophysiology of chronic neurogenic cough. Thus pharmacologic neuromodulators have been used in patients with chronic neurogenic cough to reduce cough severity and to improve cough-related quality of life.

Best Practice

The use of neuromodulators appears to be helpful in patients with chronic idiopathic/neurogenic cough. Small RCTs support short-term improvement in cough-related quality of life and cough severity for pregabalin with speech therapy, amitriptyline, and gabapentin. There is also limited lower-level evidence supporting the use of baclofen. Adverse effects are common, necessitating appropriate counseling when initiating treatment; however, no serious complications were reported. Data on long-term effects are mixed. Further studies, ideally including both patient-reported outcome measures and objective measures of cough, are necessary to draw conclusions on superior agent(s), dosing regimen, optimal duration of therapy, the individual versus combined benefits of neuromodulating agents and speech therapy, and long-term outcomes (Laryngoscope. 2017;127:1007–1008).

Filed Under: Laryngology, Laryngology, Practice Focus, TRIO Best Practices Tagged With: chronic idiopathic cough, chronic neurogenic cough, laryngology, neuromodulators, treatmentIssue: November 2017

You Might Also Like:

  • Superior Laryngeal Nerve Block May Be a Viable Treatment Option for Neurogenic Cough
  • Procedural Therapies Demonstrate Effectiveness in Improving the Lives of Patients with Neurogenic Cough
  • Neurogenic Cough Is Often a Diagnosis of Exclusion
  • Superior Laryngeal Nerve Block Improves Neurogenic Cough for Most

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939